logo
Toggle navigation
  • Login
  • Glycosciences Homepage
  • Glycan Library
  • Data
  • Request Form
  • Software tool
logo

Broadly neutralizing anti-HIV anti-V3 loop antibody 10-188

  1. Home

Instructions | Symbol Definitions | Lipid Tag Descriptions
(Asterisks that follow the names of certain probes indicate that predominant components are shown.)

Get Data as CSV | Get Data as XLS



  
  
Experiment NameBroadly neutralizing anti-HIV anti-V3 loop antibody 10-188
Associated PublicationComplex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.
Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, Scheid JF, Halper-Stromberg A, Gnanapragasam PN, Spencer DI, Seaman MS, Schuitemaker H, Feizi T, Nussenzweig MC, Bjorkman PJ
Proceedings of the National Academy of Sciences of the United States of America, 109, E3268-77
2012 Nov 20
Analyte Name10-188
Analyte FamilyAntibodies
Analyte InformationAn anti-V3 loop antibody (Mouquet H, et al. PLoS One 6(9):e24078. 2011) used as a positive control antibody in the studies of binding activities of antibodies in the PGT121-like and 10-1074-like groups.
Concentration50 ug/mL
ProtocolAfter blocking arrayed slides with 0.04% (v/v) Blocker Casein (Pierce), 1% (w/v) bovine serum albumin (Sigma A8577) in Hepes buffered saline (5 mM Hepes, pH 7.4, 150 mM NaCl, 5 mM CaCl2), 10-188 was analyzed at 50 ug/ml, followed by biotinylated anti-human IgG (Vector) 5 ug/ml. Binding was detected using Alexa Fluor-647-labeled streptavidin from Molecular Probes (1 ug/ml). As diluent the blocker solution was used.
Other CommentsN/A